DINFECTOME
Created to Cure Infections
迪飞首页背景
Pathogen NGS Detection
One-Stop solution
英文手机端
Company Profile
Founded in 2018, Dinfectome is a leading high-tech company specialized in the research, development, and service provision of clinical molecular diagnostics for pathogens. Our team comprises hundreds of professionals from top-tier universities globally, with expertise across multiple disciplines. Currently, Dinfectome collaborates with over 1,500 clinical experts across more than 700 leading hospitals. We also operate medical testing centers in key cities including Nanjing, Shanghai, Guangzhou, Beijing, and Chengdu to enhance report turnaround times and meet clinical demands.
迪飞英文按钮
Development Journey
50505050
Information Centre
News
05/ 10/ 2024
Difei Academic | mNGS reveals changes in intestinal flora and related drug resistance genes in children in PICU after antibiotic treatment

Recently, Difei Medical collaborated with the team of Zhu Xiaodong, PICU of Xinhua Hospital Affiliated to Shanghai Jiao Tong University, and published 'Pediatric intensive care unit treatment alters the diversity and composition of the gut microbiota and antimicrobial resistance gene expression in critical' in Frontiers in Microbiology (IF=5.200) ill children》.The article comprehensively reveals the community structure of the intestinal flora of children in PICU, and compares the differences in intestinal flora, gene functions, and changes in metabolism-related pathways in children before and after short-term antibiotic treatment.

企业微信截图_17153244046043.png
05/ 10/ 2024
Diffei Academic | mNGS reveals the role of lung microbiota in primary graft dysfunction in lung transplant recipients

Recently, the Department of Respiratory and Critical Care Medicine of the China-Japan Friendship Hospital cooperated with Diffei Medical to conduct mNGS detection on the bronchoalveolar lavage fluid of 32 patients with lung transplantation and primary graft dysfunction (PGD) to explore the The role of local microbiota in lung transplant patients complicated with PGD.Studies have shown that there are changes in the lung flora of patients with PGD grade 3, and the imbalance of lung flora is related to lung immunity.The research results have been published in The Journal of Clinical and Transplantation Research.

企业微信截图_17153200434475.png
05/ 11/ 2024
[Good news] Difei Medical was selected into the list of specialized and new small and medium-sized enterprises in Jiangsu Province

On May 6, the list of Jiangsu Province's 2024 specialized and new small and medium-sized enterprises (the first batch) was announced. After strict selection and review, Difei Medical Technology (Nanjing) Co., Ltd. relied on its focus and breakthroughs in the field of pathogen detection. and innovation, and successfully obtained the 'Specialized, Specialized and New' small and medium-sized enterprise certification!

企业微信截图_17154155124829.png
Dinfectome Online
迪飞在线点击按钮英文版面-820x155px

About Dinfectome

Telephone: + 86 - 4006362325
E-mail: marketing@dinfectome.com
Address: No.128 Huakang Road, Jiangbei New District, Nanjing, Jiangsu Province, China
Leave a Message
Cooperation

Follow Us

Copyright© 2023 Difei Medical Technology (Nanjing) Co., Ltd. Su ICP No. 20046744-2 All rights reserved | Sitemap | Privacy Policy | Leadong support